Diabetic nephropathy. Type 2 diabetes mellitus with kidney complications
Conditions
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: Diagnosis of diabetic nephropathy confirmed by a specialist - - being in the age range of 25 to 75 years clinically in stage 3 (eGFR equivalent to 30 to 59) or stage 4 (eGFR equivalent to 15 to 29) chronic kidney disease age 25-75 years old
Exclusion criteria
Exclusion criteria: not performing hemodialysis or peritoneal dialysis presence of liver, gastrointestinal, stroke and ischemic heart disease (3 months after stroke and ischemic heart disease), pulmonary disease (asthma and COPD), cancer, hypothyroidism and hyperthyroidism, gastric ulcer, infectious especially hepatitis, garlic allergy No pregnancy and lactation not consuming drugs of anticoagulants such as heparin, warfarin, apixaban, uvaroxaban, penicillamine and 3 months after taking antibiotics No history of taking garlic supplements and no special diet in the last 3 months Not smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Beginning of study - week 8. Method of measurement: Digital scales.;Waist circumference. Timepoint: Beginning of study - week 8. Method of measurement: strip meter.;Body mass index. Timepoint: Beginning of study - week 8. Method of measurement: formula.;Mild arm circumference. Timepoint: Beginning of study - week 8. Method of measurement: stripe meter.;Fasting blood sugar. Timepoint: Beginning of study - week 8. Method of measurement: biochemical assesment.;Triglycerides. Timepoint: Beginning of study - week 8. Method of measurement: biochemical assessment.;Low density lipoprotein- cholesrtol. Timepoint: Beginning of study - week 8. Method of measurement: formula.;High density lipoprotein-cholestrol. Timepoint: Beginning of study - week 8. Method of measurement: biochemical assessment.;Total cholestrol. Timepoint: Beginning of study - week 8. Method of measurement: biochemical assessment.;Fasting insulin. Timepoint: Beginning of study - week 8. Method of measurement: biochemical assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Estimated glomerular filtration rate. Timepoint: Beginning of the study - week 8. Method of measurement: Formula.;Blood urea nitrogen. Timepoint: Beginning of the study - week 8. Method of measurement: Biochemical assessment.;Creatinine. Timepoint: Beginning of the study - week 8. Method of measurement: Biochemical assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Saraf-Bank
Esfahan University of Medical Sciences
Outcome results
None listed